Biology Reference
In-Depth Information
[264] Bell SL, Chiang AN, Brodsky JL. Expression of a malarial
Hsp70 improves defects in chaperone-dependent activities in
ssa1 mutant yeast. PLoS One 2009;6:e20047.
[265] Bilsland E, Pir P, Gutteridge A, et al. Functional expression of
parasite drug targets and their human orthologs in yeast. PLoS
Negl Trop Dis 2011;5:e1320.
[266] Breitenbach M, Jazwinski SM, Laun. P, editors. Aging Research
in Yeast. Subcellular Biochemistry, vol. 57. New York: Springer;
2012. p. 365.
[267] Bharadwaj P, Martins R, Macreadie I. Yeast as a model for
studying Alzheimer's disease. FEMS Yeast Res 2010;10:961
e
9.
[268] Lindquist S. Using yeast to understand protein folding diseases:
an interview with Susan Lindquist by Kristin Kain. Dis Model
Mech 2008;1:17
e
9.
[269] De Vos A, Anandhakumar J, Van den Brande J, et al. Yeast as
a model system to study tau biology. Int J Alzheimers Dis 2011
(2011), Article ID 428970.
[270] Mason RP, Giorgini F. Modeling Huntington disease in yeast:
perspectives and future directions. Prion 2011;5(4):269
e
76.
[271] McGurk L, Bonini NM. Cell biology. Yeast informs Alzheimer's
disease. Science 2011;334:1212
e
3.
[272] Ocampo A, Barrientos A. Developing yeast models of human
neurodegenerative
[283] Mattanovich D, Branduardi P, Dato L, et al. Recombinant
protein production in yeasts. Methods Mol Biol 2012;
824:329
58.
[284] Soh KC, Miskovic L, Hatzimanikatis V. From network models to
network responses: integration of thermodynamic and kinetic
properties of yeast genome-scale metabolic networks. FEMS
Yeast Res 2012;12:129
e
43.
[285] Kim IK, Rold˜o A, Siewers V, et al. A systems-level approach for
metabolic engineering of yeast cell factories. FEMS Yeast Res.
2012;12:228
e
48.
[286] Nielsen J, Pronk JT. Metabolic engineering, synthetic biology and
systems biology. FEMS Yeast Res 2012;12:103.
[287] Da Vinci L. Trattato della pittura. Parte prima/23. Carabba
Editore. Manuscript compiled from the originals by F. Melzi. 1540.
Leonardo Digital Edition (LDE VU) page 14v. F. Fiorani digital
project. University of Virginia,
http://www.treatiseonpainting.org/
[288] Oliver SG. Yeast as a navigational aid in genome analysis.
Microbiology 1997;143:1483
e
7.
[289] Oliver SG. Functional genomics: lessons from yeast. Philos Trans
R Soc Lond B Biol Sci 2002;357:17
e
23.
[290] Winzeler EA, Shoemaker DD, Astromoff A, et al. Functional
characterization of the S. cerevisiae genome by gene deletion and
parallel analysis. Science 1999;285:901
e
disorders. Methods Mol Biol
2011;
793:113
e
27.
[273] Zhang N, Bilsland E. Contributions of Saccharomyces cerevisiae
to understanding mammalian gene function and therapy. Methods
Mol Biol 2011;759:501
6.
[291] Giaever G, Chu AM, Ni L, et al. Functional profiling of the
Saccharomyces cerevisiae genome. Nature 2002;418:387
e
91.
[292] MacLellan WR, Wang Y, Lusis AJ. Systems-based approaches to
cardiovascular disease. Nat Rev Cardiol 2012;9:172
e
84.
[293] Sperling SR. Systems biology approaches to heart develop-
ment and congenital heart disease. Cardiovasc Res 2011;91:
269
e
78.
[294] Antony PM, Diederich NJ, Balling R. Parkinson's disease mouse
models
e
23.
[274] Couthouis J, Hart MP, Shorter J, et al. A yeast functional screen
predicts new candidate ALS disease genes. Proc Natl Acad Sci
U S A 2011;108:20881
e
90.
[275] Couplan E, Aiyar RS, Kucharczyk R, et al. A yeast-based assay
identifies drugs active against human mitochondrial disorders.
Proc Natl Acad Sci U S A. 2011;108:11989
e
94.
[276] Tardiff DF, Tucci ML, Caldwell KA, et al. Different 8-hydrox-
yquinolines protect models of TDP-43 protein,
a
-synuclein, and
polyglutamine proteotoxicity through distinct mechanisms. J Biol
Chem. 2012;287:4107
e
20.
[277] Neef DW, Turski ML, Thiele DJ. Modulation of heat shock
transcription factor 1 as a therapeutic target for small molecule
intervention in neurodegenerative disease. PLoS Biol 2010;8:
e1000291.
[278] Park SK, Pegan SD, Mesecar AD, et al. Development and vali-
dation of a yeast high-throughput screen for inhibitors of A
b
oligomerization. Dis Model Mech 2011;4:822
e
31.
[279] Bharucha N, Kumar A. Yeast genomics and drug target identifi-
cation. Comb Chem High Throughput Screen 2007;10:618
e
34.
[280] Andrusiak K, Piotrowski JS, Boone C. Chemical
e
genomic
profiling: systematic analysis of the cellular targets of bioactive
molecules. Bioorg Med Chem 2012;20:1952
e
in
translational
research. Mamm
Genome
2011;22:401
e
19.
[295] Cox B, Kotlyar M, Evangelou AI, et al. Comparative systems
biology of human and mouse as a tool to guide the modeling of
human placental pathology. Mol Syst Biol 2009;5:279.
[296] Mori MA, Liu M, Bezy O, et al. A systems biology approach
identifies inflammatory abnormalities between mouse strains
prior to development of metabolic disease. Diabetes 2010;59:
2960
e
71.
[297] O'Callaghan PM, James DC. Systems biotechnology of
mammalian cell factories. Brief Funct Genomic Proteomics.
2008;7:95
e
110.
[298] Stuart LM, Boulais J, Charriere GM, et al. A systems
biology analysis of the Drosophila phagosome. Nature 2007;445:
95
e
101.
[299] Yu D, Corbett B, Yan Y, et al. Early cerebrovascular inflammation
in a transgenic mouse model of Alzheimer's disease. Neurobiol
Aging 2012. 2012 Mar 20. [Epub ahead of print] PubMed PMID:
22440674.
[300] Goto JJ, Tanzi RE. The role of the low-density lipoprotein
receptor-related protein (LRP1) in Alzheimer's A beta generation:
development of a cell-based model system. J Mol Neurosci.
2002;19:37
e
41.
60.
[281] Proctor M, Urbanus ML, Fung EL, et al. The automated cell:
compound and environment screening system (ACCESS) for
chemogenomic
e
screening. Methods Mol
Biol
2011;
69.
[282] De Jong B, Siewers V, Nielsen J. Systems biology of yeast:
enabling technology for development of cell factories
for production of advanced biofuels. Curr Opin Biotechnol 2012;
23(4):624
e
30.
759:239
e
[301]
Joyner MJ, Pedersen BK. Ten questions about systems biology.
J Physiol 2011;589:1017
e
30.
